Pale Fire Capital SE Purchases 275,000 Shares of Phreesia, Inc. $PHR

Pale Fire Capital SE lifted its position in shares of Phreesia, Inc. (NYSE:PHR) by 3.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,924,329 shares of the company’s stock after buying an additional 275,000 shares during the quarter. Phreesia makes up 2.5% of Pale Fire Capital SE’s investment portfolio, making the stock its 6th largest position. Pale Fire Capital SE owned about 0.14% of Phreesia worth $91,831,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Royal Bank of Canada lifted its stake in shares of Phreesia by 208.8% during the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company’s stock worth $617,000 after purchasing an additional 16,309 shares during the period. AQR Capital Management LLC lifted its position in Phreesia by 471.2% during the first quarter. AQR Capital Management LLC now owns 160,032 shares of the company’s stock worth $4,090,000 after buying an additional 132,015 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Phreesia by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company’s stock worth $1,599,000 after buying an additional 2,158 shares during the last quarter. NewEdge Advisors LLC increased its stake in shares of Phreesia by 262.7% during the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company’s stock valued at $395,000 after acquiring an additional 11,181 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Phreesia by 0.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company’s stock worth $15,336,000 after acquiring an additional 2,402 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Stock Up 0.3%

NYSE PHR opened at $11.88 on Thursday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $31.83. The business has a 50 day moving average price of $11.19 and a two-hundred day moving average price of $10.48. The stock has a market cap of $734.30 million, a PE ratio of 79.20 and a beta of 0.86.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The firm had revenue of $129.46 million for the quarter, compared to analysts’ expectations of $129.06 million. During the same quarter in the prior year, the business earned $0.01 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, sell-side analysts predict that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia generated positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, strengthening its balance sheet and supporting profitability expansion. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with the $515 million analyst consensus, reducing the risk of a near-term outlook cut. The company also identified AccessOne as a potential multi-year growth driver. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Needham & Company issued a Buy rating, providing favorable analyst support for PHR following the earnings release. Phreesia Earns Buy Rating from Needham
• Neutral Sentiment: Revenue reached $129.46 million, up 10.4% year over year and slightly above the $129.06 million consensus estimate, indicating continued growth but not a major top-line upside surprise. Phreesia fiscal second-quarter results
• Negative Sentiment: Quarterly EPS was $0.03, below analyst expectations of approximately $0.09 to $0.11, although it improved from $0.01 in the prior-year quarter. The earnings shortfall may weigh on investor sentiment despite the company’s cash-flow progress. Phreesia Q2 earnings and revenues lag estimates

Wall Street Analysts Forecast Growth

PHR has been the subject of several research analyst reports. Barclays reaffirmed an “equal weight” rating and set a $10.00 price target (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $9.00 target price (down from $15.00) on shares of Phreesia in a research report on Wednesday, May 20th. Needham & Company LLC restated a “buy” rating and set a $14.00 price target on shares of Phreesia in a research note on Monday. Weiss Ratings upgraded Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday, July 20th. Finally, Truist Financial lifted their price objective on Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a research note on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $16.65.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.